As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >


Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >


Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Innovate with us

Discover >
Genopole’s Citizen

Genopole governance

The Groupement d’intérêt public (GIP, a form of public-private partnership for missions of public interest) Genopole continues to serve thanks to the unfailing support of its 12 members, five of which are fund providers. The GIP has policy and scientific strategy bodies to guide the assurance of its missions.

The biocluster receives stable support from a number of public entities (French State, Île-de-France Regional Council, etc.) who contribute significant funding for investments in and the functioning of shared-use technological platforms and the teams serving Genopole’s labs and businesses.

GIP Genopole General Meeting

The General Meeting is composed of representatives designated by each member institution. The General Meeting administers and makes all decisions concerning the GIP:

  • adoption of the budget,
  • annual program.

It also deliberates nominations to the Committee for Science, Innovation and Industry (CSII) and elects the president and vice-president.

General Meeting members

Stéphane Beaudet - Portrait


Stéphane Beaudet

President of Genopole

Marianne Duranton

Île-de-France Region

Marianne Duranton

Vice-President of Genopole

AFM-Téléthon Evry


Laurence Thiennot-Herment

CEA Sponsor of Genopole


Elsa Cortijo


CHSF - logo


Mélanie Jullian


Agglo Grand Paris Sud - Logo

Grand Paris Sud

Stéphane Raffalli


The department of Essonne - Logo

Essonne, The department

Laure Darcos

Inserm - Logo


Claire Giry


Ministry of Higher Education, Research and Innovation

Ministry of Higher Education, Research and Innovation

Anne Paoletti


SEM Genopole - Genopole technical platform reception structure

SEM Genopole

Fabrice Taratte


UEVE - University of Evry - Logo

Université d'Evry

Patrick Curmi


Committee For Science, Innovation And Industry (CSII)

The CSII is composed of qualified persons with particular competencies in Genopole’s fields of activity. Its members are approved by the General Meeting. The role of the CSII is to provide the General Meeting with opinions and recommendations on the scientific and industrial orientations of GIP Genopole. A seat on the CSII is accorded intuiti personae and the members act in strict independence of their affiliations.

CSII President

Christian Lajoux - Président de Medicen Paris RegionChristian Lajoux:

From 2015 to 2021, Christian Lajoux was  president of Medicen Paris Region, a world-scale competitiveness cluster dedicated to innovative technologies for health and new therapeutics.

He has also served as president of the Carnot Committee since 2014.

Earlier in his career, Christian Lajoux held several posts within the Sandoz Group—now Novartis—before joining Sanofi in 1993. There, he was successively Chief Executive Officer of the French subsidiary, president Europe and president of all Sanofi activities in France.

He was president of the French Federation of Healthcare Industries (FEFIS) and, as such, member of the executive committee and office of MEDEF (France’s largest employer federation), wherein he leads the health committee among others.

Christian Lajoux is currently president of IFIS, an institute for health industries training.

CSII Members

  • Florence Agostino-Etchetto, CEO – Lyonbiopole
  • Emmanuel Barillot, Team Leader – Institut Curie
  • Nadine Bongaerts-Duportet, Administrative Board Member – Hello Tomorrow
  • Fayza Daboussi, Director of Life Sciences – Toulouse White Biotechnology
  • Olivier Dugas, Deputy Technical Lead, Precision Farming – Limagrain
  • Marco Fiorini, Executive Director – ARIIS
  • Philippe Gesnouin, EIT Digital & EIT Health Project Officer – Inrae
  • Xavier Gidrol, Director of the Large Scale Biology laboratory and the Biomics laboratory – CEA
  • David Guerrand, Biotech Business Director – Lallemand
  • Christophe Junot, Research Director – CEA
  • Sophie Kornowski, Senior Partner – Gurnet Point Capital
  • Philippe Lavocat, Chief Executive Officer – GENCI
  • Franck Molina, Director of Public-Private Research Center – SyséDiag (CNRS-Alcediag)
  • Sylvie Ponchaut, Managing Director – BioWin
  • Eric Quemeneur, Executive Vice President and R&D Vice President – Transgene SA
  • Emmanuelle Quilès, Chief Executive Officer – Janssen France
  • Sébastien Ribault, Vice-President – Merck Life Sciences
  • Dominique Stoppa-Lyonnet, Professor of Genetics, Paris-Descartes University, and Head of Genetics – Institut Curie
With the support from